Market cap
$13.275 M
$1.89 -4.06%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
-$13.6M
Loss-making
Shares outstanding
5,179,378
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Industrial Specialties — ranked by market cap
All 55 →Where these numbers come from
Share counts and financials for Regentis Biomaterials are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.